CClinicalTrials.gg
Not yet recruitingNCT07433894Updated Feb 27, 2026

Scoliosis and Functional Outcomes in Children With Juvenile Idiopathic Arthritis

An observational study in Scoliosis, sponsored by Istanbul University. Not yet recruiting. Open to participants aged 8 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-27.

Sponsored by Istanbul University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
8 Years to 18 Years
Sex
All
01

Study summary

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease that may affect musculoskeletal development and posture in children. Spinal involvement, including scoliosis, is not routinely evaluated in clinical practice despite its potential impact on functional status and quality of life.

This cross-sectional study aims to assess the presence of scoliosis in children with JIA and to investigate its association with functional status, postural alignment, and disease activity. Clinical and functional parameters will be analyzed to better understand the impact of spinal deformities in this population.

Read the detailed description

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease that may negatively affect musculoskeletal development, posture, and overall physical function in children. Although peripheral joint involvement is well characterized, axial and postural abnormalities, including scoliosis, are not routinely assessed during follow-up despite their potential clinical significance.

This cross-sectional study aims to evaluate the presence of scoliosis in children with JIA and to investigate its relationship with disease activity, functional status, pain, and postural alignment. Comprehensive clinical assessments, including physical examination, disease activity scores, and functional evaluation tools, will be performed. Where applicable, postural analysis and imaging findings will also be considered.

By identifying the frequency and clinical impact of scoliosis in JIA, this study seeks to improve awareness of spinal involvement and to provide a basis for early recognition and multidisciplinary management strategies, including targeted physiotherapy interventions.

02

Conditions studied

  • Scoliosis

Keywords

  • Juvenile Idiopathic Arthritis
  • Scoliosis
  • Functional Outcomes
  • Postural Alignment
  • Pediatric Rheumatology
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's planned enrollment of 200 is above the median of 89 across 233 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Istanbul University is the lead sponsor of 496 studies on the registry; 79 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of children and adolescents aged 8-18 years diagnosed with juvenile idiopathic arthritis (JIA) according to ILAR criteria and followed up at a tertiary pediatric rheumatology center. Participants will be recruited consecutively during routine outpatient visits. The aim of the study is to evaluate the prevalence and severity of scoliosis, as defined by Cobb angle measurements on physical examination and, if necessary, standing spinal radiographs, and to examine its relationship with clinical and functional parameters. Both patients with and without scoliosis will be included in the study.

Inclusion criteria

  • Age between 8 and 18 years at the time of enrollment
  • Diagnosis of juvenile idiopathic arthritis (JIA) according to ILAR criteria
  • Written informed consent obtained from parent/legal guardian and assent from the child/adolescent, when appropriate

Exclusion criteria

Exclusion Criteria

  • Known scoliosis due to non-JIA causes (e.g., congenital vertebral anomalies, neuromuscular disorders, or syndromic scoliosis)
  • History of prior spinal surgery or current brace treatment for scoliosis
  • History of significant spinal trauma or spinal infection/tumor affecting spinal alignment
  • Presence of coexisting chronic conditions that significantly affect posture, gait, or functional testing (e.g., severe neurologic impairment) and may confound assessments
  • Inability to undergo required assessments (e.g., inability to stand for radiographs or complete functional measures)
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • JIA Patients With Scoliosis

    Children diagnosed with juvenile idiopathic arthritis (JIA) who have scoliosis, defined by a Cobb angle of ≥10 degrees on standing spinal radiographs. Clinical characteristics, disease activity parameters, and functional assessments including postural and plantar pressure analyses will be evaluated. No intervention will be applied; this group will be observationally assessed.

  • JIA Patients Without Scoliosis

    Children diagnosed with juvenile idiopathic arthritis (JIA) without evidence of scoliosis (Cobb angle \<10 degrees). Participants will undergo the same clinical, laboratory (if applicable), and functional assessments as the scoliosis group. This is an observational group with no intervention.

06

What researchers measure

Primary outcomes

  1. Prevalence of Scoliosis in Children With Juvenile Idiopathic Arthritis

    Proportion of participants with scoliosis, defined as a Cobb angle ≥10° measured on standing spinal radiographs.

    Time frame: At baseline (single study visit)

Secondary outcomes

  1. Scoliosis Severity (Cobb Angle)

    Cobb angle (degrees) measured on standing spinal radiographs. Scoliosis defined as Cobb angle ≥10°.

    Time frame: At baseline (single study visit)

  2. Health-Related Quality of Life (PedsQL)

    Health-related quality of life assessed using the Pediatric Quality of Life Inventory (PedsQL) total score (and physical and psychosocial subscale scores, if available). Scores are transformed to a 0-100 scale (range: 0-100), with higher scores indicating better health-related quality of life.

    Time frame: At baseline (single study visit)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — The decision to share individual participant data (IPD) has not yet been finalized. Data sharing may be considered upon reasonable request after publication, subject to institutional policies, ethical approvals, and data protection regulations.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07433894
Lead sponsor
Istanbul University
Responsible party
Bengisu Menentoğlu (Principal Investigator, Istanbul University) — Principal investigator
First posted
Feb 25, 2026
Start date
Apr 1, 2026 (estimated)
Primary completion
Jun 1, 2026 (estimated)
Completion
Jul 1, 2026 (estimated)
Last update
Feb 27, 2026

Study contacts

Bengisu Menentoğlu
Contact
bengisusanisoglu@gmail.com
+905359523337

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion